Equities researchers at William Blair issued their FY2028 earnings estimates for Tempest Therapeutics in a research report ...

Stock analysts at William Blair issued their Q2 2025 earnings estimates for StoneX Group in a research report issued on Wednesday, March 26th. William Blair analyst J. Schmitt forecasts that the ...

The footwear and sportswear industries face a slew of challenges as their main sourcing regions are hit with high tariffs.

Rollins also has a lean business model. Capital expenditure as a percentage of sales has averaged around 1 per cent over the past five years. Cash flow has been steady too, meaning management has been ...

Operator: Good day, and thank you for standing by. Welcome to the UniFirst Second Quarter 2025 Earnings Conference Call. At ...

Tesla reported first-quarter vehicle deliveries of 336,681 before Wednesday's stock market open Wednesday. That was worse ...

Analysts are keeping a keen eye on any hint of a consumer slowdown – the fuel for the U.S. economy. They were laser focused ...

In a report released today, Ryan Daniels from William Blair reiterated a Buy rating on HealthStream (HSTM – Research Report). The company’s ...

William Blair analyst Margaret Kaczor maintained a Buy rating on Penumbra (PEN – Research Report) today. The company’s shares opened today at ...

William Blair Large Cap Growth Fund earns an Average ... they may cut payouts if their earnings decline. Similarly, in recent months, the strategy also had less exposure to the Yield factor ...